Your browser doesn't support javascript.
loading
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
Abraham, William T; Lindenfeld, JoAnn; Ponikowski, Piotr; Agostoni, Piergiuseppe; Butler, Javed; Desai, Akshay S; Filippatos, Gerasimos; Gniot, Jacek; Fu, Michael; Gullestad, Lars; Howlett, Jonathan G; Nicholls, Stephen J; Redon, Josep; Schenkenberger, Isabelle; Silva-Cardoso, José; Störk, Stefan; Krzysztof Wranicz, Jerzy; Savarese, Gianluigi; Brueckmann, Martina; Jamal, Waheed; Nordaby, Matias; Peil, Barbara; Ritter, Ivana; Ustyugova, Anastasia; Zeller, Cordula; Salsali, Afshin; Anker, Stefan D.
  • Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, 473 West 12th Ave., Columbus, OH 43210, USA.
  • Lindenfeld J; Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232, USA.
  • Ponikowski P; Wroclaw Medical University, Wybrzeze L. Pasteura 1, 50-367, Wroclaw, Poland.
  • Agostoni P; Centro Cardiologico Monzino-IRCCS, Via Carlo Parea, 4 - 20138, Milan, Italy.
  • Butler J; Department of Clinical Sciences and Community Health, University of Milan, Via della Commenda 19 20122, Milan, Italy.
  • Desai AS; Department of Medicine, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS-39216, USA.
  • Filippatos G; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
  • Gniot J; National and Kapodistrian University of Athens, School of Medicine, Athens 157 72, Greece.
  • Fu M; University of Cyprus, School of Medicine, Shacolas Educational Centre for Clinical Medicine, Palaios dromos Lefkosias Lemesou No.215/6, 2029 Aglantzia, Nicosia, Cyprus.
  • Gullestad L; Department of Cardiology, Independent Public Healthcare, General Hospital in Pulawy; ul. Bema 1; 24 - 100 Pulawy, Poland.
  • Howlett JG; Section of Cardiology, Department of Medicine, Sahlgrenska University Hospital/Östra Hospital, Gothenburg University, Blå stråket 5, 413 45 Gothenburg, Sweden.
  • Nicholls SJ; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Redon J; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Søsterhjemmet, Kirkeveien 166, 2.etasje, 0450 Oslo, Norway.
  • Schenkenberger I; KG Jebsen Center for Cardiac Research, University of Oslo, Sogn Arena, Klaus Torgårds vei 3, 2. Etg, 0372 Oslo, Norway.
  • Silva-Cardoso J; Center for Heart Failure Research, Department of Cardiology Medicine (Building 3), 1st floor, Oslo University Hospital, Kirkeveien 166, 0407 Oslo, Norway.
  • Störk S; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr NW, Calgary, AB T2N 4N1, Canada.
  • Krzysztof Wranicz J; Monash Cardiovascular Research Centre, Monash University, 27 Rainforest Walk, Clayton VIC 3800, Melbourne, Australia.
  • Savarese G; INCLIVA Research Institute, University of Valencia, vinguda de Menéndez y Pelayo, 4, 46010 Valencia, and CIBERObn, Madrid, Spain.
  • Brueckmann M; Klinische Forschung Berlin GbR, Ansbacher Str. 17-19, 10787 Berlin, Germany.
  • Jamal W; CardioCare, CINTESIS-Center for Health Technology and Services Research, and Director of the Cardiology Service, Porto University Medical School, São João University Medical Centre, Rua Dr. Plácido da Costa, s/n 4200-450, Porto, Portugal.
  • Nordaby M; Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, Würzburg University and University Hospital Würzburg, Straubmühlweg 2, 97078 Würzburg, Germany.
  • Peil B; Department of Electrocardiology, Medical University of Lodz, al. Tadeusza Kosciuszki 4, 90-41, Lodz, Poland.
  • Ritter I; Department of Medicine, Karolinska Institutet, Solna Karolinska University Hospital D1:04, SE-171 76 Stockholm, Sweden.
  • Ustyugova A; Boehringer Ingelheim International GmbH, Binger Str. 173, 55216 Ingelheim am Rhein, Germany.
  • Zeller C; Faculty of Medicine Mannheim, University of Heidelberg, Ludolf-Krehl-Str. 13-17, 68167 Mannheim, Germany.
  • Salsali A; Boehringer Ingelheim International GmbH, Binger Str. 173, 55216 Ingelheim am Rhein, Germany.
  • Anker SD; Boehringer Ingelheim International GmbH, Binger Str. 173, 55216 Ingelheim am Rhein, Germany.
Eur Heart J ; 42(6): 700-710, 2021 02 11.
Article en En | MEDLINE | ID: mdl-33351892
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article